Adult Vaccine Market Report

Global Adult Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：181
  • REPORT CODE：GMM831491
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Adult Vaccine market report explains the definition, types, applications, major countries, and major players of the Adult Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Merck

    • Novartis

    • BioCSL (Seqirus)

    • Protein Sciences

    • Pfizer

    • Sanofi Pasteur

    • GlaxoSmithKline

    By Type:

    • Influenza

    • Cervical Cancer

    • Zoster Shingles

    • Pneumococcal

    • Meningococcal

    • MMRV

    • Hepatitis

    • DTP

    • Travel and Miscellaneous

    By End-User:

    • Hospitals

    • Medical Care Centers

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Adult Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Adult Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Adult Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Adult Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Adult Vaccine Market- Recent Developments

    • 6.1 Adult Vaccine Market News and Developments

    • 6.2 Adult Vaccine Market Deals Landscape

    7 Adult Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Adult Vaccine Key Raw Materials

    • 7.2 Adult Vaccine Price Trend of Key Raw Materials

    • 7.3 Adult Vaccine Key Suppliers of Raw Materials

    • 7.4 Adult Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Adult Vaccine Cost Structure Analysis

      • 7.5.1 Adult Vaccine Raw Materials Analysis

      • 7.5.2 Adult Vaccine Labor Cost Analysis

      • 7.5.3 Adult Vaccine Manufacturing Expenses Analysis

    8 Global Adult Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Adult Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Adult Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Adult Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Adult Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Zoster Shingles Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Pneumococcal Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Meningococcal Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MMRV Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Hepatitis Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global DTP Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Travel and Miscellaneous Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adult Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Care Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Adult Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Adult Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Adult Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Adult Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Adult Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Adult Vaccine Consumption (2017-2022)

      • 10.3.2 UK Adult Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Adult Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Adult Vaccine Consumption (2017-2022)

      • 10.3.5 France Adult Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Adult Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Adult Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Adult Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Adult Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Adult Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Adult Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Adult Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Adult Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Adult Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Adult Vaccine Consumption (2017-2022)

      • 10.4.3 India Adult Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Adult Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Adult Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Adult Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Adult Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Adult Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Adult Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Adult Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Adult Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Adult Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Adult Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Adult Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Adult Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Adult Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Adult Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Adult Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Adult Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Adult Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Adult Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Adult Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Adult Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Adult Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Adult Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Adult Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Adult Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Adult Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Adult Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Adult Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Adult Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Adult Vaccine Consumption (2017-2022)

    11 Global Adult Vaccine Competitive Analysis

    • 11.1 Merck

      • 11.1.1 Merck Company Details

      • 11.1.2 Merck Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Merck Adult Vaccine Main Business and Markets Served

      • 11.1.4 Merck Adult Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis

      • 11.2.1 Novartis Company Details

      • 11.2.2 Novartis Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis Adult Vaccine Main Business and Markets Served

      • 11.2.4 Novartis Adult Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 BioCSL (Seqirus)

      • 11.3.1 BioCSL (Seqirus) Company Details

      • 11.3.2 BioCSL (Seqirus) Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 BioCSL (Seqirus) Adult Vaccine Main Business and Markets Served

      • 11.3.4 BioCSL (Seqirus) Adult Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Protein Sciences

      • 11.4.1 Protein Sciences Company Details

      • 11.4.2 Protein Sciences Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Protein Sciences Adult Vaccine Main Business and Markets Served

      • 11.4.4 Protein Sciences Adult Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Pfizer

      • 11.5.1 Pfizer Company Details

      • 11.5.2 Pfizer Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Pfizer Adult Vaccine Main Business and Markets Served

      • 11.5.4 Pfizer Adult Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi Pasteur

      • 11.6.1 Sanofi Pasteur Company Details

      • 11.6.2 Sanofi Pasteur Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi Pasteur Adult Vaccine Main Business and Markets Served

      • 11.6.4 Sanofi Pasteur Adult Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 GlaxoSmithKline

      • 11.7.1 GlaxoSmithKline Company Details

      • 11.7.2 GlaxoSmithKline Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 GlaxoSmithKline Adult Vaccine Main Business and Markets Served

      • 11.7.4 GlaxoSmithKline Adult Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Adult Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Adult Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Zoster Shingles Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global MMRV Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global DTP Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Travel and Miscellaneous Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Adult Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Adult Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Adult Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Adult Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Adult Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Adult Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Adult Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Adult Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Adult Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Adult Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Adult Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Adult Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Adult Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Adult Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Adult Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Adult Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Adult Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Adult Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Adult Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Adult Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Adult Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Adult Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Adult Vaccine

    • Figure of Adult Vaccine Picture

    • Table Global Adult Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Adult Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Zoster Shingles Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Consumption and Growth Rate (2017-2022)

    • Figure Global MMRV Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis Consumption and Growth Rate (2017-2022)

    • Figure Global DTP Consumption and Growth Rate (2017-2022)

    • Figure Global Travel and Miscellaneous Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Vaccine Consumption by Country (2017-2022)

    • Table North America Adult Vaccine Consumption by Country (2017-2022)

    • Figure United States Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Adult Vaccine Consumption by Country (2017-2022)

    • Figure Germany Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Adult Vaccine Consumption by Country (2017-2022)

    • Figure China Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Adult Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Adult Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Adult Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Adult Vaccine Consumption by Country (2017-2022)

    • Figure Australia Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Table Merck Company Details

    • Table Merck Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Adult Vaccine Main Business and Markets Served

    • Table Merck Adult Vaccine Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Adult Vaccine Main Business and Markets Served

    • Table Novartis Adult Vaccine Product Portfolio

    • Table BioCSL (Seqirus) Company Details

    • Table BioCSL (Seqirus) Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCSL (Seqirus) Adult Vaccine Main Business and Markets Served

    • Table BioCSL (Seqirus) Adult Vaccine Product Portfolio

    • Table Protein Sciences Company Details

    • Table Protein Sciences Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Adult Vaccine Main Business and Markets Served

    • Table Protein Sciences Adult Vaccine Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Adult Vaccine Main Business and Markets Served

    • Table Pfizer Adult Vaccine Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Adult Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur Adult Vaccine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Adult Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Adult Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Adult Vaccine Product Portfolio

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Zoster Shingles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MMRV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DTP Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Travel and Miscellaneous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Adult Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US